Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Minocycline hydrochloride 50mg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Minocycline hydrochloride 100mg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely minocycline hydrochloride 75 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Minocycline hydrochloride 50mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Minocycline hydrochloride 100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Minocycline hydrochloride 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Minocycline hydrochloride 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Minocycline hydrochloride 1mg oral microspheres |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely minocycline hydrochloride 75 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline hydrochloride 75 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline hydrochloride 75 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 100 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Minocycline hydrochloride dihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 75 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 20 milligram/1 gram conventional release periodontal gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Minocycline hydrochloride |
Inferred relationship |
Some |
1 |